Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Debt to Equity (2019 - 2025)

Biodesix (BDSX) has disclosed Debt to Equity for 7 consecutive years, with -$19.25 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity fell 1203.63% year-over-year to -$19.25, compared with a TTM value of -$19.25 through Dec 2025, down 1203.63%, and an annual FY2025 reading of -$19.25, down 1203.63% over the prior year.
  • Debt to Equity was -$19.25 for Q4 2025 at Biodesix, up from -$27.36 in the prior quarter.
  • Across five years, Debt to Equity topped out at $41.11 in Q2 2025 and bottomed at -$30.61 in Q3 2023.
  • Average Debt to Equity over 5 years is -$0.73, with a median of $1.45 recorded in 2021.
  • The sharpest move saw Debt to Equity soared 4027.09% in 2021, then plummeted 2210.43% in 2025.
  • Year by year, Debt to Equity stood at $1.41 in 2021, then grew by 21.91% to $1.72 in 2022, then surged by 626.61% to $12.46 in 2023, then tumbled by 86.01% to $1.74 in 2024, then crashed by 1203.63% to -$19.25 in 2025.
  • Business Quant data shows Debt to Equity for BDSX at -$19.25 in Q4 2025, -$27.36 in Q3 2025, and $41.11 in Q2 2025.